ibandronic acid has been researched along with Spinal Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, W; Dong, Y; Li, P; Rhodesm, SD; Shen, Y; Wang, Y; Xue, X; Zhang, B; Zhang, W; Zhang, Y | 1 |
| Correa, PD; Han, S; Rizwanullah, M; Shrimali, RK | 1 |
| Kurth, AH | 1 |
3 other study(ies) available for ibandronic acid and Spinal Neoplasms
| Article | Year |
|---|---|
Administration of sodium ibandronate in the treatment of complicated giant cell tumor of the spine.
Topics: Adult; Bone Density Conservation Agents; Diphosphonates; Female; Giant Cell Tumors; Humans; Ibandronic Acid; Spinal Neoplasms; Treatment Outcome; Young Adult | 2011 |
Positron emission tomography with computed tomography (PET-CT) to evaluate the response of bone metastases to non-surgical treatment.
Topics: Aromatase Inhibitors; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Ibandronic Acid; Letrozole; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Nitriles; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Tomography, X-Ray Computed; Triazoles | 2010 |
[Oral and parenteral forms of aminobisphosphonate].
Topics: Administration, Oral; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Colorectal Neoplasms; Diphosphonates; Humans; Ibandronic Acid; Infusions, Intravenous; Osteolysis; Spinal Neoplasms | 2004 |